More than 200 UK agencies that provide ‘CE’ safety labels may lose recognition after March 2019

NHS Against Brexit is the grassroots campaign fighting to protect UK health and social care from the negative effect Brexit would have on the country. We believe that the jobs of NHS staff from EU countries can't be threatened, that free movement and tariff-free borders are vital to get the medicines we need into the country, and that there is no Brexit dividend.

Have you ever been in a Twitter debate about Brexit where you just can't remember where you saw that stat? Or been talking to someone close to you who doesn't quite believe that the NHS will be damaged by Brexit? That's where we come in!

The Brexit bulletin is produced by the NHS Confederation European Office in order to bring together all the latest Brexit news for the health and care sector.

Find out more about what is at risk for healthcare if the UK does not reach a Brexit deal in this infographic from the Brexit Health Alliance.

Brexiteers who claimed the NHS would receive an extra £350m after Brexit have been condemned for voting down an amendment demanding an analysis of the impact of exiting the EU on the health service.

A prolonged economic fallout as a result of Brexit could have a chilling effect on the NHS budget, writes the head of the NHS European Office.

In this rather fiery and impassioned episode of #3Blokes In A Pub, we talk to scientist Dr Mike Galsworthy about #Brexit's impact on medicine and the NHS.

Deal or no deal, here are the issues that need fixing by March 29.

So how would a no-deal Brexit affect cancer patients and research?

In this thread Steve Analyst reviews submissions from US businesses on their requirements for a US-UK trade deal including: lower food, contamination and safety standards; removing labels for traceability; admission of GMO; ...

Brexit poses a real risk to the health of children in the UK, with concerns over recruiting specialist doctors and access to research funding, according to a new report.

The Swiss pharmaceuticals company Novartis has said it is stockpiling drugs in the UK before a possible no-deal Brexit, which it warned would be “hugely impactful” for patients.

Last week the Home Office launched an app for EU citizens, but it has spread anxiety.

Theresa May’s offer was supposed to reassure the 3 million from Europe who call Britain home. But therapists report many are profoundly affected

The government's lack of clarity over how the UK's immigration system will work after Brexit could leave the NHS spending up to half a billion pounds per year on international recruitment, explains RCP president-elect Dr Andrew Goddard.

San Francisco-based clinical-stage life science company Recardio is halting clinical trials in the U.K. of a new heart drug due to concerns about Brexit and how new drugs will be approved.

Department of Health writes to trusts advising of contingency plans for short supply of imported ingredients.

Crashing out without a deal could contribute to an additional 12,400 cardiovascular deaths between 2021 and 2030, according to the research published in the journal BMJ Open on Monday.

To estimate the potential impacts of different Brexit trade policy scenarios on the price and intake of fruits and vegetables (F&V) and consequent cardiovascular disease (CVD) deaths in England between 2021 and 2030.

Britain faces expulsion from a medical network that helps to identify and treat conditions that affect tens of thousands.